# Catherine Kopil

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/catherine-kopil/

## Facts

| Field | Value |
| --- | --- |
| Citations | 3,138 |
| Field | Parkinson's Disease Mechanisms and Treatments |
| h-index | 24 |
| i10-index | 38 |
| Last Known Institution | Michael J. Fox Foundation |
| OpenAlex ID | https://openalex.org/A5020663082 |
| ORCID iD | 0000-0001-8678-7550 |
| Works | 84 |

## Researcher papers

- [Current and projected future economic burden of Parkinson’s disease in the U.S.](https://scholariq.org/papers/current-and-projected-future-economic-burden-of-parkinson-s-disease-in-the-u-s/)
- [A biological definition of neuronal α-synuclein disease: towards an integrated staging system for research](https://scholariq.org/papers/a-biological-definition-of-neuronal-synuclein-disease-towards-an-integrated/)
- [Experience induces structural and biochemical changes in the adult primate brain](https://scholariq.org/papers/experience-induces-structural-and-biochemical-changes-in-the-adult-primate-brain/)
- [Longitudinal CSF biomarkers in patients with early Parkinson disease and healthy controls](https://scholariq.org/papers/longitudinal-csf-biomarkers-in-patients-with-early-parkinson-disease-and-healthy/)
- [In vivo distribution of α-synuclein in multiple tissues and biofluids in Parkinson disease](https://scholariq.org/papers/in-vivo-distribution-of-synuclein-in-multiple-tissues-and-biofluids-in-parkinson/)
- [Finding useful biomarkers for Parkinson’s disease](https://scholariq.org/papers/finding-useful-biomarkers-for-parkinson-s-disease/)
- [Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study](https://scholariq.org/papers/clinical-and-dopamine-transporter-imaging-characteristics-of-non-manifest-lrrk2/)
- [Fox Insight collects online, longitudinal patient-reported outcomes and genetic data on Parkinson’s disease](https://scholariq.org/papers/fox-insight-collects-online-longitudinal-patient-reported-outcomes-and-genetic/)
- [Candidate inflammatory biomarkers display unique relationships with alpha-synuclein and correlate with measures of disease severity in subjects with Parkinson’s disease](https://scholariq.org/papers/candidate-inflammatory-biomarkers-display-unique-relationships-with-alpha/)
- [The BioFIND study: Characteristics of a clinically typical Parkinson's disease biomarker cohort](https://scholariq.org/papers/the-biofind-study-characteristics-of-a-clinically-typical-parkinson-s-disease/)
- [Contribution of neuropsychiatric symptoms in Parkinson’s disease to different domains of caregiver burden](https://scholariq.org/papers/contribution-of-neuropsychiatric-symptoms-in-parkinson-s-disease-to-different/)

## Researcher topics

- [Parkinson's Disease Mechanisms and Treatments](https://scholariq.org/topics/parkinson-s-disease-mechanisms-and-treatments/)
- [Neuroinflammation and Neurodegeneration Mechanisms](https://scholariq.org/topics/neuroinflammation-and-neurodegeneration-mechanisms/)
- [Nuclear Receptors and Signaling](https://scholariq.org/topics/nuclear-receptors-and-signaling/)
- [Neurological disorders and treatments](https://scholariq.org/topics/neurological-disorders-and-treatments/)
- [Autism Spectrum Disorder Research](https://scholariq.org/topics/autism-spectrum-disorder-research/)

## Researcher university

- [Michael J. Fox Foundation](https://scholariq.org/institutions/michael-j-fox-foundation/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.